World Health Summit 2016

October 09-11

Venue:
Federal Foreign Office
Unterwasserstraße 10
10117 Berlin, Germany

Technological Innovation for Health

Improving Healthcare Diagnostics and Delivery

Translational Research

Advancing Innovative Treatment

Monday, Oct. 10, 2016
16:00-18:00
Plenary Hall (Weltsaal)

Successful health care delivery requires effective medical devices as tools for prevention, diagnosis, treatment and rehabilitation. As the digital and genetics revolutions converge with healthcare, we are increasingly able to track, manage, and improve both our own health and that of our loved ones. Technological innovation in the field of health is also helping reduce inefficiencies in healthcare delivery, while at the same time streamlining access, reducing costs, improving quality and making medicine more personalized and precise.

Chair:
- Tarik Möröy
  (President, Clinical Research Institute Montreal,
   Canada)

Speakers:
- Jutta Allmendinger
  (President, Berlin Social Science Center (WZB),
   Germany)
- Yukiya Amano
  (Director-General, International Atomic Energy
   Agency, Austria)
- Pascale Ehrenfreund
  (Chairman of the Board, German Aerospace
   Center (DLR), Germany)
- Lloyd B. Minor
  (Dean, Stanford University,
   School of Medicine, USA)
- Steve Singh
  (President, Business Networks and Applications,
   SAP SE, USA)
- Frans van Houten
  (CEO, Royal Philips NV, Netherlands)

Tuesday, Oct. 11, 2016,
11:00-12:30
Plenary Hall (Weltsaal)

Translational research helps turn early-stage innovations into new health products, advancing the innovation to the point where it becomes attractive for further development by the medical industry or healthcare agencies. Although research in academia and in companies produces many new discoveries and inventions that have the potential to improve health, turning those ideas into deliverable products can prove extremely difficult.

Chairs:
- Christina Mitchell
  (Monash University, Australia)

Speakers:
- Elizabeth Blackburn
  (Nobel Prize laureate / President, Salk
   Institute for Biological Studies, USA)
- Dario Campana
  (Director, National University
   Cancer Institute, Singapore)
- Angelika Eggert
  (Director, Department of Pediatrics,
   Charité - Universitätsmedizin Berlin, Germany)
- Stephen M. Jane
  (Head, Central Clinical School,
   Monash University, Australia)
- Michael J. Klag
  (Dean, Johns Hopkins Bloomberg School
   of Public Health, USA)

Governance for Health

Tackling Corruption in the Healthcare Sector

Panel Discussion
Room 1 (Europasaal)

In this session, Transparency International will introduce the findings of their new report on corruption risks in the health sector, which will be published on the event of the World Health Summit 2016.

Chronic Kidney Disease in Sri Lanka

A Public Health Crisis of Unknown Aetiology

Workshop
Room 5 (Rathenau)

A mysterious kidney disease has been killing thousands of farmers in Sri Lanka's rice basket. In 20 years, the disease has taken up to 20,000 lives and sickened up to 400,000 more people. We don’t yet know what causes the condition.

A student conference on Antimicrobial Resistance, a health hackathon, an open data hack day, a German-African healthcare symposium, and a whole conference on "Refugee Migration and Health" - the WHS 2016 brings you an eclectic additional program.

Follow this link to find out more about the
WHS 2016 Satellite Events >>>

The mission of the new Department of Environmental Health and Engineering is to improve the health of the Earth and its inhabitants. Its academic and research activities span the science of biological processes, environmental engineering, environmental and health policy, and data analytics.

It features 264 students, 82 full-time faculty members and offers 11 degrees.

Find out all about the Johns Hopkins Bloomberg School of Public Health at our M8 Alliance Member Page >>>

       ^{(c) Johns Hopkins Bloomberg School of Public Health}

“Universities are an important partner to government, business and the wider community in the implementation of the SDGs and this role should be recognized and resourced,” says Monash’s Professor John Thwaites, Chair of the UN Sustainable Development Solutions Network (SDSN) Australia/Pacific.

Find out all about Monash University at our M8 Alliance Member Page >>>

Researchers from University of Montreal, Polytechnique Montréal and McGill University have developed new nanorobotic agents capable of navigating through the bloodstream to administer a drug with precision by specifically targeting the active cancerous cells of tumors (details >>>). As a result, a drug dosage that is highly toxic for the human organism could be significantly reduced.

Find out all about Montreal University at our M8 Alliance Member Page >>>

       ^{(c) Polytechnique Montréal}